ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: Results of the second comprehensive national audit of ACS patients

New Zealand Medical Journal

Volumn 123, Issue 1319, 2010, Pages

  Ellis, Chris ^a   Devlin, Gerard ^b   Elliott, John ^c   Matsis, Philip ^d   Williams, Michael ^e   Gamble, Greg ^f   Hamer, Andrew ^g   Richards, Mark ^h   White, Harvey ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b WAIKATO HOSPITAL   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d WELLINGTON HOSPITAL   (New Zealand)

^e DUNEDIN HOSPITAL   (New Zealand)

^f UNIVERSITY OF AUCKLAND   (New Zealand)

^g NELSON HOSPITAL   (New Zealand)

^h UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CASE MANAGEMENT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE UTILIZATION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NEW ZEALAND; RISK FACTOR; THERAPY DELAY; ANGIOCARDIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; DELAYED DIAGNOSIS; HEALTH CARE DELIVERY; HOSPITAL ADMISSION; LENGTH OF STAY; MIDDLE AGED; MORTALITY; PATIENT TRANSPORT; PUBLIC HEALTH; RADIOGRAPHY; STATISTICS; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; UTILIZATION REVIEW;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DELAYED DIAGNOSIS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MEDICAL AUDIT; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; NEW ZEALAND; PATIENT ADMISSION; PATIENT TRANSFER; SURVIVAL RATE; YOUNG ADULT;

EID: 77955103420     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Elliott J, Richards M. Heart attacks and unstable angina (acute coronary syndromes) have doubled in New Zealand since 1989: how do we best manage the epidemic? NZ Med J 2005;118(1223). http//www.nzma.org.nz/journal/118-1223/1674
2. Bassand J, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of cardiology. Eur Heart J 2007;28:1598-1660.
3. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of cardiology. Eur Heart J 2008;29:2909-2945.
4. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary. J Am Coll Cardiol 2007;50:652-726.
5. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction. J Am Coll Cardiol 2008;51:210-247.
6. Non ST-Elevation Acute Coronary Syndrome Guidelines Group and the New Zealand Branch of the Cardiac Society of Australia and New Zealand. Non ST-elevation myocardial infarction: New Zealand management guidelines. NZ Med J 2005;118:1-19. http://www.nzma.org.nz/journal/118-1223/1680
7. ST-Elevation Acute Coronary Syndrome Guidelines Group and the New Zealand Branch of the Cardiac Society of Australia and New Zealand. ST-elevation myocardial infarction: New Zealand management guidelines. NZ Med J 2005;118(1223). http://www.nzma.org.nz/journal/118-1223/1679
8. Ellis C, Gamble G, French J, et al. Management of patients admitted with an Acute Coronary Syndrome in New Zealand: Results of a comprehensive nationwide audit. NZ Med J 2004;117(1197). http://www.nzma.org.nz/journal/117-1197/953
9. Ellis C, Devlin G, Matsis P, et al. Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities. NZ Med J 2004;117(1197). http://www.nzma.org.nz/journal/ 117-1197/954
10. Conaglen P, Sebastian C, Jayaraman C, et al. Management of unstable angina and non-ST elevation myocardial infarction: do cardiologists do it better? A comparison of secondary and tertiary centre management in New Zealand. NZ Med J 2004;117(1194). http://www.nzma.org.nz/journal/117-1194/890.
11. Tang EW, Wong CK, Herbison P. Community hospital versus tertiary hospital comparison in the treatment and outcome of patients with acute coronary syndrome: a New Zealand experience. NZ Med J 2006;119(1238). http://www.nzma.org.nz/journal/119-1238/2078.
12. Insull P, Kejriwal R, Patel H, et al. Is it possible to distribute a scarce resource equitably? Access to invasive procedures for patients with acute myocardial infarction. NZ Med J 2007;120(1250). http://www.nzma.org.nz/journal/ 120-1250/2446.
13. Wong C, Tang EW, Herbison P. Survival over 5 years in the initial hospital survivors with acute coronary syndrome: a comparison between a community and a tertiary hospital in New Zealand. NZ Med J 2007;120(1261). http://www.nzma.org.nz/journal/120-1261/2713.
14. Ellis C, Gamble G, Hamer A, et al. Patients admitted with an Acute Coronary Syndrome in New Zealand in 2007: Results of a second comprehensive nationwide audit and a comparison with the first audit from 2002. N Z Med J. 2010;123(1319). http://www.nzma.org.nz/journal/123-1319/4235
15. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003;361:13-20. (Pubitemid 36050955)
16. Boden EB, Eagle K, Granger CB. Reperfusion strategies in acute ST-segment elevation myocardial infarction. A comprehensive review of contemporary management options. J Am Coll Cardiol 2007;50:917-929.
17. Henry TD, Sharkey SW, Burke MN, et al. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation 2007;116:721-728.
18. Antman EM. Time is Muscle; Translation into practice. J Am Coll Cardiol 2008;52:1216-1221.
19. Gershlick AH, Stephens-Lloyd A, Hughes S, et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 2005;353:2758-68.
20. Patel T, Bavry AA, Khumbani D, Ellis SG. A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis. Am J Cardiol 2006;97:1685-1690. (Pubitemid 43817850)
21. White HD. Systems of Care. Need for hub-and-spoke systems for both primary and systematic percutaneous coronary intervention after fibrinolysis. Circulation 2008;118:219-222.
22. Cantor WJ, Fitchett D, Borgundvaag B, et al. for the TRANSFER-AMI Trial Investigators. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009;360:2705-2718.
23. Verheugt FWA. Routine angioplasty after fibrinolysis-how early should 'early' be? N Eng J Med 2009;360:2779-2781.
24. Bavry AA, Kumbhani DJ, Rassi AN, et al. Benefit of early invasive therapy in acute coronary syndromes. A meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 2006;48:1319-1325.
25. Fox KAA, Poole-Wilson P, Clayton TC, et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 2005;366:914-920.
26. Briffa T, Hickling S, Knuiman M, et al. Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005. BMJ 2009;338:b36 doi:10.1136/bmj.b36.
27. Neutze J, Haydock D. Prioritisation and cardiac events while waiting for coronary bypass surgery in New Zealand. NZ Med J 2000;113:69-70.
28. Ellis CJ, Hamer AW. Cardiovascular health in New Zealand: areas of concern and targets for improvement in 2008 and beyond. NZ Med J 2008;121:5-10. http://www.nzma.org.nz/journal/121-1269/2927
29. Bonaca MP, Steg PG, Feldman LJ, et al. Antithrombotics in acute coronary syndromes. J Am Coll cardiol 2009;54:969-984.
30. Ellis CJ, Zambanini A, French JK, et al. Inadequate control of lipid levels in patients with a previous myocardial infarction. NZ Med J 1998;111:464-467. (Pubitemid 28565599)
31. White H, Ellis C. PHARMAC and the lack of funding for clopidogrel. NZ Med J 2006;119(1228). http://www.nzmj.com/journal/119-1228/1808/content.pdf
32. Ellis C, White H. PHARMAC and the statin debacle. NZ Med J 2006;119(1236). http://www.nzma.org.nz/journal/119-1236/2003
33. Swinburn B, Milne R, Richards M, et al. Reimbursement of pharmaceuticals in New Zealand: comments on PHARMAC's processes. NZ Med J 2000;113:425-427.
34. Mehta RH, Montoye CK, Faul JF, et al. Enhancing quality of care for acute myocardial infarction: shifting the focus of improvement from key indicators to process of care and tool use. J Am Coll Cardiol 2004;43:2166-2173.
35. Eagle KA, Montoyne CK, Riba AL, et al. Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute coronary infarction. The American College of Cardiology's Guidelines applied in practice (GAP) projects in Michigan. J Am Coll Cardiol 2005;46:1242-1248.
36. Bridgman P. The challenge of improving cardiac care in secondary centres. NZ Med J 2004;117 (1194). http://www.nzma.org.nz/journal/117-1194/888
37. Wong CK. Barriers to a better management for acute coronary syndrome-insights from the Otago-Southland ACS Registry, 2000-2002. NZ Med J 2009;122 (1290). http://www.nzma.org.nz/journal/122-1290/3492